• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

6050 例成年起病生长激素缺乏患者接受生长激素替代治疗前糖尿病患病率:KIMS 分析。

Prevalence of diabetes mellitus in 6050 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis.

机构信息

Antwerp Centre for Endocrinology, Grotesteenweg 556, B-2600 Berchem, Antwerp, Belgium.

出版信息

Eur J Endocrinol. 2013 Feb 15;168(3):297-305. doi: 10.1530/EJE-12-0807. Print 2013 Mar.

DOI:10.1530/EJE-12-0807
PMID:23211573
Abstract

OBJECTIVE

GH deficiency (GHD) in adults is characterized by a tendency toward obesity and an adverse body composition with visceral fat deposit and may thus predispose to the development of type 2 diabetes mellitus. The aim of this study was to assess the observed prevalence proportion (PP) and observed PP over expected PP ratio (standardized prevalence proportion ratio, SPR) of diabetes according to International Diabetes Federation criteria in a large cohort of GH-untreated adult-onset GHD patients.

DESIGN AND METHODS

Associations between baseline variables and diabetes prevalence in 6050 GHD patients from KIMS (Pfizer International Metabolic Database) were studied and robust Poisson-regression analyses were performed. Comparisons between baseline status and HbA1c categories in the nondiabetic patients were done with covariance analysis. P values <0.05 were considered statistically significant.

RESULTS

PP was 9.3% compared with the expected 8.2%. SPR was 1.13 (95% confidence intervals (95% CIs), 1.04-1.23), which was significantly increased in females (1.23; 95% CI, 1.09-1.38%) but not in males (SPR 1.04; 95% CI, 0.92-1.17%). PP increased significantly by age, familial diabetes, country selection, BMI, waist circumference, number of pituitary deficiencies, and GHD etiology. SPR decreased significantly by age and increased significantly by BMI, waist circumference, and IGF1 SDS. Multiple regression model showed that the most important impact on SPR was from age and BMI. HbA1c values of 6.0-6.5% were found in 9.5% of nondiabetic patients and were associated with higher BMI and waist circumference.

CONCLUSIONS

GHD is associated with an increased prevalence of diabetes, largely to be explained by the adverse body composition. These data urge toward early initiation of lifestyle modification measures.

摘要

目的

成人生长激素缺乏症(GHD)的特征是倾向于肥胖和不良的身体成分,内脏脂肪沉积,因此可能导致 2 型糖尿病的发生。本研究的目的是根据国际糖尿病联合会(IDF)的标准,评估大量未经 GH 治疗的成年起病 GHD 患者中糖尿病的观察到的现患率(PP)和观察到的现患率与预期现患率的比值(标准化现患率比,SPR)。

设计和方法

研究了 KIMS(辉瑞国际代谢数据库)中 6050 例 GHD 患者的基线变量与糖尿病患病率之间的关系,并进行了稳健泊松回归分析。对非糖尿病患者的基线状况和 HbA1c 分类进行了协方差分析。P 值<0.05 被认为具有统计学意义。

结果

PP 为 9.3%,而预期值为 8.2%。SPR 为 1.13(95%置信区间[95%CI],1.04-1.23),女性明显升高(1.23;95%CI,1.09-1.38%),而男性无明显升高(SPR 1.04;95%CI,0.92-1.17%)。PP 随年龄、家族性糖尿病、国家选择、BMI、腰围、垂体功能减退症数量和 GHD 病因显著增加。SPR 随年龄显著降低,随 BMI、腰围和 IGF1 SDS 显著增加。多元回归模型显示,对 SPR 最重要的影响因素是年龄和 BMI。非糖尿病患者中 6.0-6.5%的 HbA1c 值发现与较高的 BMI 和腰围有关。

结论

GHD 与糖尿病的患病率增加有关,主要原因是不良的身体成分。这些数据敦促尽早开始生活方式改变措施。

相似文献

1
Prevalence of diabetes mellitus in 6050 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis.6050 例成年起病生长激素缺乏患者接受生长激素替代治疗前糖尿病患病率:KIMS 分析。
Eur J Endocrinol. 2013 Feb 15;168(3):297-305. doi: 10.1530/EJE-12-0807. Print 2013 Mar.
2
Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database.成年患者孤立性生长激素(GH)缺乏症:与垂体功能减退患者相比的基线临床特征及GH替代治疗反应。KIMS数据库的一项亚分析
Growth Horm IGF Res. 2005 Oct;15(5):349-59. doi: 10.1016/j.ghir.2005.06.018.
3
Prevalence and characteristics of the metabolic syndrome in 2479 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis.2479 例成年起病生长激素缺乏患者接受生长激素替代治疗前的代谢综合征患病率和特征:KIMS 分析。
Eur J Endocrinol. 2011 Dec;165(6):881-9. doi: 10.1530/EJE-11-0599. Epub 2011 Oct 3.
4
Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults - a KIMS database analysis.2589例垂体功能减退性生长激素缺乏成人患者心血管风险的决定因素——一项KIMS数据库分析
Eur J Endocrinol. 2006 Jul;155(1):79-90. doi: 10.1530/eje.1.02179.
5
Baseline characteristics and response to 2 years of growth hormone (GH) replacement of hypopituitary patients with GH deficiency due to adult-onset craniopharyngioma in comparison with patients with nonfunctioning pituitary adenoma: data from KIMS (Pfizer International Metabolic Database).与无功能垂体腺瘤患者相比,成人起病的颅咽管瘤导致生长激素(GH)缺乏的垂体功能减退患者的基线特征及2年GH替代治疗反应:来自KIMS(辉瑞国际代谢数据库)的数据
J Clin Endocrinol Metab. 2005 Aug;90(8):4636-43. doi: 10.1210/jc.2005-0185. Epub 2005 May 31.
6
Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults.老年垂体功能减退成人生长激素缺乏与替代的相关方面。
Growth Horm IGF Res. 2004 Jun;14 Suppl A:S51-8. doi: 10.1016/j.ghir.2004.03.013.
7
GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety.1034例生长激素缺乏型垂体功能减退成人患者的生长激素替代治疗:人口统计学和临床特征、剂量及安全性
Clin Endocrinol (Oxf). 1999 Jun;50(6):703-13. doi: 10.1046/j.1365-2265.1999.00695.x.
8
Growth hormone deficiency and replacement in elderly hypopituitary adults. KIMS Study Group and the KIMS International Board. Pharmacia and Upjohn International Metabolic Database.老年垂体功能减退成人的生长激素缺乏与替代治疗。KIMS研究组及KIMS国际委员会。法玛西亚和普强国际代谢数据库。
Clin Endocrinol (Oxf). 2000 Sep;53(3):281-9. doi: 10.1046/j.1365-2265.2000.01104.x.
9
Cardiovascular risk factors in hypopituitary GH-deficient adults.垂体功能减退性生长激素缺乏成年患者的心血管危险因素
Eur J Endocrinol. 2009 Nov;161 Suppl 1:S41-9. doi: 10.1530/EJE-09-0291. Epub 2009 Aug 14.
10
The pituitary gland and age-dependent regulation of body composition.垂体与年龄相关的身体成分调节。
J Clin Endocrinol Metab. 2010 Aug;95(8):3664-74. doi: 10.1210/jc.2009-2506. Epub 2010 May 19.

引用本文的文献

1
Cardiovascular Risk Factors in Sheehan's Syndrome: A Case-Control Study.席汉氏综合征中的心血管危险因素:一项病例对照研究。
Indian J Endocrinol Metab. 2024 May-Jun;28(3):260-267. doi: 10.4103/ijem.ijem_297_23. Epub 2024 Jun 26.
2
Serum afamin and its implications in adult growth hormone deficiency: a prospective GH-withdrawal study.血清 afamin 及其在成人生长激素缺乏症中的意义:一项前瞻性 GH 撤药研究。
Front Endocrinol (Lausanne). 2024 Feb 6;15:1348046. doi: 10.3389/fendo.2024.1348046. eCollection 2024.
3
Cell non-autonomous regulation of cerebrovascular aging processes by the somatotropic axis.
体轴对脑血管衰老过程的非自主调控。
Front Endocrinol (Lausanne). 2023 Jan 23;14:1087053. doi: 10.3389/fendo.2023.1087053. eCollection 2023.
4
Long-Term Safety of Growth Hormone Deficiency Treatment in Cancer and Sellar Tumors Adult Survivors: Is There a Role of GH Therapy on the Neoplastic Risk?癌症和鞍区肿瘤成年幸存者生长激素缺乏症治疗的长期安全性:生长激素治疗在肿瘤风险方面有作用吗?
J Clin Med. 2023 Jan 13;12(2):662. doi: 10.3390/jcm12020662.
5
Growth Hormone Replacement Therapy Seems to Be Safe in Children with Low-Grade Midline Glioma: A Series of 124 Cases with Review of the Literature.生长激素替代疗法在低级别中线胶质瘤儿童中似乎是安全的:124例病例系列及文献综述
Cancers (Basel). 2022 Dec 22;15(1):55. doi: 10.3390/cancers15010055.
6
Decreased lifespan in female "Munchkin" actors from the cast of the 1939 film version of The Wizard of Oz does not support the hypothesis linking hypopituitary dwarfism to longevity.出演 1939 年电影版《绿野仙踪》的“马骝精”女演员寿命缩短,这一事实不支持将垂体功能减退性侏儒症与长寿联系起来的假说。
Geroscience. 2022 Oct;44(5):2527-2539. doi: 10.1007/s11357-022-00680-7. Epub 2022 Nov 5.
7
Pituitary function and the response to GH therapy in patients with Langerhans cell histiocytosis: analysis of the KIMS database.朗格汉斯细胞组织细胞增生症患者的垂体功能和 GH 治疗反应:KIMS 数据库分析。
Eur J Endocrinol. 2022 Jul 21;187(3):373-381. doi: 10.1530/EJE-22-0160. Print 2022 Sep 1.
8
Growth hormone deficiency and NAFLD: An overlooked and underrecognized link.生长激素缺乏与非酒精性脂肪性肝病:一个被忽视和低估的关联。
Hepatol Commun. 2022 Sep;6(9):2227-2237. doi: 10.1002/hep4.1953. Epub 2022 Jun 28.
9
Development of a Novel Algorithm to Identify People with High Likelihood of Adult Growth Hormone Deficiency in a US Healthcare Claims Database.在美国医疗保健理赔数据库中开发一种新型算法以识别成年人生长激素缺乏症高可能性人群。
Int J Endocrinol. 2022 Jun 18;2022:7853786. doi: 10.1155/2022/7853786. eCollection 2022.
10
Effects of adult growth hormone deficiency and replacement therapy on the cardiometabolic risk profile.成年人生长激素缺乏症及替代疗法对心血代谢风险特征的影响。
Pituitary. 2022 Apr;25(2):211-228. doi: 10.1007/s11102-022-01207-1. Epub 2022 Feb 1.